Source comparison
Melanotan-1 Research Timeline: Protocol Design Comparison
In Vitro (Human Melanocyte Culture) 10–15 minutes 24–48 hours 5–7 days (intracellular melanin) Day 5–10 for Fontana-Masson staining Best for isolating cellular kinetics; no systemic variables. Requires high-purity peptide and controlled pH (7.2–7.4). Subcutane
This comparison does not assign a generated winner or score.
- In Vitro (Human Melanocyte Culture)
- 10–15 minutes
- 24–48 hours
- 5–7 days (intracellular melanin)
- Day 5–10 for Fontana-Masson staining
- Best for isolating cellular kinetics; no systemic variables. Requires high-purity peptide and controlled pH (7.2–7.4).
- Subcutaneous (Murine Models)
- 15–30 minutes
- 36–48 hours
- 7–10 days (coat darkening)
- Day 10–14 for maximal pigmentation
- Reflects real-world pharmacokinetics; slower onset due to depot absorption. Standard route for photoprotection studies.
- Intravenous Bolus (Murine Models)
- 24–36 hours
- 5–7 days (coat darkening)
- Day 7–10 for maximal pigmentation
- Achieves supramaximal receptor occupancy immediately. Compresses timeline but requires precise dosing to avoid transient hypotension.
- Ex Vivo (Human Skin Explants)
- 48–72 hours
- 7–10 days (epidermal melanin transfer)
- Day 10–14 for keratinocyte melanin content
- Maintains tissue architecture; best for studying melanosome transfer. Requires fresh tissue (≤24 hours post-excision) and culture under physiological O₂ (5% vs 21%).